This team develops policies to minimize the risk of future pandemics from the deliberate misuse of bioweapons, or accidental releases of dangerous pathogens, which are amplified by emerging technologies. Our work covers the governance of bio-research and supply chains, the detection and surveillance systems, transmission-blocking infrastructure, and outbreak containment capabilities.

Scroll to Top